Since it was established in 1987 as one of the first Italian CROs, Farmastudio has worked closely with the major University and International Pharmaceutical Companies.
In that time Farmastudio has successfully completed over 400 Phase I to IV clinical trials both in adult and paediatric patients in many different therapeutic areas including:

  • Cardiology
    • Hypertension
    • Acute Coronary Syndrom
  • Endocrinology
    • Type 1 diabetes mellitus
    • Type 2 diabetes mellitus
    • Secondary hyperparathyroidis
  • Gastroenterology
    • Dyspepsia
  • Haematology
    • Leukaemia
    • Bone marrow transplant
    • Thalassemia
  • Infectious Diseases
    • Chronic hepatitis B
    • Chronic hepatitis C
    • HIV
  • Nephrology
    • Renal Anaemia
  • Neurology
    • Alzheimer
  • Oncology
    • Breast cancer
    • Gastric cancer
    • Ovarian cancer
    • Lung cancer
  • Ophthalmology
    • Glaucoma
  • Pneumology
    • Asthma
  • Rare Diseases
    • Duchenne Muscular Dystrophy
  • Rheumatology
    • Rheumatoid arthritis
    • Osteoporosis

Every member of the Farmastudio team holds a scientific graduate degree and has up to 30 years’ experience in the clinical research field.

Numerous audits by our sponsors’ quality assurance staff and the FDA on our studies and sites have always received positive results without significant deficiencies in protocol, regulatory compliance and data integrity.